In vitro production of dendritic cells from cd14+ monocytes

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/0784 (2010.01) C12N 5/071 (2010.01) C12N 5/0786 (2010.01) A61K 35/14 (2006.01) C12N 5/02 (2006.01) C12Q 1/02 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2469792

The invention relates to the use of CD14+ monocytes for the production of dendritic cells. The invention comprises the use of CD14+ monocytes isolated from peripheral circulating blood for obtaining, by differentiation, at least one mixed population of Langerhans cells and interstitial dendritic cells, both Langerhans cells and interstitial dendritic cells being preconditioned and undifferentiated, and/or differentiated and immature, and/or mature, and/or interdigitated. The invention comprises their use in suspension, monolayer and three-dimensional cell and tissue models. The invention comprises the use of these cells and of these models as study models for the assessment of immunotoxicity/immunotolerance, for the development of cosmetic and pharmaceutical active principles and for the development and implementation of methods of cell and tissue therapy.

L'invention concerne l'utilisation de monocytes CD14?+¿ pour la production de cellules dendritiques. L'invention comprend l'utilisation de monocytes CD14?+¿ isolés à partir de sang de circulation périphérique, pour obtenir, par différenciation au moins une population mélangée de cellules de Langerhans et de cellules dendritiques interstitielles, à la fois les cellules de Langerhans et les cellules dendritiques interstitielles étant préconditionnées et indifférenciées, et/ou différenciées, et non mûres et/ou mûres, et/ou interdigitées. L'invention concerne l'utilisation de modèles tissulaires et cellulaires tridimensionnels et monocouches. L'invention concerne l'utilisation de ces cellules et de ces modèles en tant que modèles d'études pour évaluer l'immunotoxicité/l'immunotolérance, pour le développement de principes actifs cosmétiques et pharmaceutiques, et pour le développement et la mise en oeuvre de procédés de thérapie cellulaire et tissulaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

In vitro production of dendritic cells from cd14+ monocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In vitro production of dendritic cells from cd14+ monocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro production of dendritic cells from cd14+ monocytes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1890266

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.